April 20, 2024
Stocks & Bonds
[STOCK WATCH] KDPharm falls 1.06%
[THE INVESTOR] As of May 29 02:40 P.M., KDPharm declined 1.06%, compared with yesterday, to 18,650 won. It had declined 1.58% through the past month. Standard deviation, the volatility index for stock price, was 1% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of KDPharm was the lowest, the earnings rate over one month was also relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.5%. Though the volatility was the lowest among its peer group, the return-on-risk was low as stock price decline. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 3.8, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSDAQ, since the monthly volatility of KDPharm was the lowest, the earnings rate over one month was also relatively lower than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -1.5%. Though the volatility was the lowest among its peer group, the return-on-risk was low as stock price decline. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, 3.8, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
